---
title: "Pyxis Oncology tumbles 8%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305708436.md"
description: "Pyxis Oncology fell 8.23% to US$1.450. Down 14.71% over five sessions and up 26.09% YTD."
datetime: "2026-11-16T18:20:58.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305708436.md)
  - [en](https://longbridge.com/en/news/305708436.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305708436.md)
generator: "portal-rs"
---

# Pyxis Oncology tumbles 8%

Pyxis Oncology (PYXS.US) tumbled more than **8%** during regular trading to **$1.45**.

The stock is down 14.71% over the past five sessions and up 26.09% year to date. It sits 73.87% below its 52-week high of US$5.550.

The Nasdaq Composite is down 2.67% over the past five sessions and up 5.75% year to date.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [PYXS.US](https://longbridge.com/en/quote/PYXS.US.md)

## Related News & Research

- [PYXS: MICVO showed durable responses in phase 1, supporting a planned global Phase 3 trial](https://longbridge.com/en/news/306107284.md)
- [William Blair upgrades Pyxis Oncology to Outperform from Market Perform](https://longbridge.com/en/news/306274949.md)
- [Guggenheim Remains a Buy on Pyxis Oncology (PYXS)](https://longbridge.com/en/news/306281515.md)
- [AI solves 167-year-old maths problem, Anthropic researcher claims](https://longbridge.com/en/news/306318851.md)
- [GIGABYTE Concludes AI Partner Summit, Showcasing Real-World AI Agent Solutions for Enterprise](https://longbridge.com/en/news/306311368.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**